Peri-Operative Surgical Care Optimisation for Patients Requiring Emergency Surgery
NCT ID: NCT06972017
Last Updated: 2025-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
112 participants
OBSERVATIONAL
2025-06-30
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
EGS is often referred to as "high-risk" surgery. For those patients who do survive after their surgery, many struggle with frailty and new medical problems resulting in a reduction in their quality of life (QoL).
The goal of this observational study is to explore QoL and decision-making in EGS through questionnaires and interviews with patients, families/supporters and consultants working in EGS.
Workstream 1 will involve patients and families/supporters. Workstream 2 will involve consultants.
The investigators are interested in patients who have either undergone EGS (EmLaps) or have needed but not undergone EGS (NoLaps). The investigators are interested in exploring participants (patients, families/supporters and consultants) experiences of this EmLap vs NoLap decision.
The main questions the investigators want to answer are:
* What is the long-term QOL of EmLap/NoLap patients and their family/supporters?
* How do patients and their family/supporters describe their experience of decision-making in EGS?
* What are consultant's experiences and views on decision-making in EGS?
Workstream 1 participants (patients and family members/supporters) will complete questionnaires and take part in interviews at different time-points following their decision (1 month/3 months/ 9-12 months). Questionnaires and interviews will explore QoL and decision-making in EGS.
Consultant participants will be asked to complete an online survey and/or take part in an individual interview. Both will explore decision-making in EGS.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determining Universal Processes Related to Best Outcome in Emergency Gastrointestinal Surgery: an International Evaluation
NCT02179112
Is Life Worth Living After Major Emergency GI Surgery? Patient Reported Outcome in Elderly Emergency Surgery Patients
NCT02377687
Drainage After Rectal Excision for Rectal Cancer
NCT01269567
Quality of Life After Cytoreductive Surgery and Intraperitoneal Chemotherapy
NCT03503071
Impact of Perioperative Intravenous Fluid Utilization on Postoperative Outcomes
NCT01563991
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EmLap patients
Patients who have underwent Emergency General Surgery
No interventions assigned to this group
NoLap patients
Patients who have needed but not undergone Emergency General Surgery.
No interventions assigned to this group
Families/Supporters
Family or supporter nominated by the patient participant to participate in the study alongside them.
No interventions assigned to this group
Consultants
Consultants who actively participate in Emergency General Surgery in a UK-based Hospital (Surgeons, Anaesthetists, Intensivists)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to communicate in English
* Cognitively able to complete the survey/interviews
* Able to provide informed, voluntary consent
* First line treatment is expedited, urgent or emergency abdominal surgery on the gastrointestinal tract
* Surgery can be laparoscopic or open approach
* Identified by the patient participant (only approached if nominated by patient)
* Age \>18 years old
* Able to communicate in English
* Cognitively able to complete the survey/interviews
* Able to provide informed, voluntary consent
* Key decision-makers will be identified in workstream 1 (likely: surgeons, intensivists and anaesthetists)
* Post-CCT (Certificate of Completion of Training)
* Participate in active on-call for EGS in a UK-based Hospital where they make decisions in EGS regularly
Exclusion Criteria
* NoLaps should be excluded if management involved interventional radiology or endoscopic procedures
* Patients who are offered a period of conservative treatment are not automatically NoLap if surgery may ultimately be offered
* Diagnosis of dementia or long-standing cognitive impairment
* Elective laparotomy/laparoscopy
* Diagnostic laparotomy/laparoscopy where no subsequent procedure is performed (however, if no procedure is performed because of inoperable pathology, then include)
* All surgery involving the appendix or gallbladder, including any surgery relating to complications
* Non-elective hernia repair without bowel resection or division of adhesions
* Non-elective formation of colostomy or ileostomy
* Trauma surgery (blunt or penetrating), vascular surgery, obstetric/gynaecological surgery or transplant surgery
* Surgery for pathology of oesophagus, spleen, renal tract, kidneys, liver, gallbladder and biliary tree, pancreas or urinary tract
* Age\<18 years old
* Lack of patient consent to family/supporter involvement
• Consultants not done \>2 years of on-call
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bowel Research UK
UNKNOWN
NHS Lothian
OTHER_GOV
NHS Grampian
OTHER_GOV
NHS Tayside
OTHER_GOV
University of Glasgow
OTHER
NHS Greater Glasgow and Clyde
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PhD_23017
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
UGN23SG190
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.